If more individuals have access to health insurance,  it is imperative to be sure the death rates of those with certain chronic conditions are decreasing. This is one of the statements Gregory Peck, an associate professor of Rutgers Robert Wood Johnson Medical School and an acute care surgeon, will be researching on behalf of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health.

Funded by NIH grants totaling more than $1 million through a recent two-year award from the New Jersey Alliance for Clinical and Translational Science (NJ ACTS), a Rutgers hub of the National Center for Advancing Translational Sciences, and now a four-year award from the NIDDK, Peck is on average one of just two critical care surgeons funded nationally annually creating new models of health for NIH consideration. To read the full story.